ライフサイエンスコーパス: reducing agent

1 sing tris(2-carboxyethyl)phosphine (TCEP) as reducing agent).

2 he conventional method (trisodium citrate as reducing agent).

3 , temperature, deactivator, added salts, and reducing agents).

4 e the presence of a catalyst to activate the reducing agent.

5 of the aminophosphine as both precursor and reducing agent.

6 this reaction is chemically mediated by the reducing agent.

7 arsenic precursor and aminophosphine as the reducing agent.

8 zed dichlorosilylene to be the most probable reducing agent.

9 alkaline-ethanol solution in the presence of reducing agent.

10 d surface attached redox-active polymer as a reducing agent.

11 pes were still somewhat sensitive to heat or reducing agent.

12 ncentrated NaOH solution with NaBH4 added as reducing agent.

13 icles (AuNPs), without the use of additional reducing agent.

14 oxylate acting as both the carbon source and reducing agent.

15 either methane or methanol, depending on the reducing agent.

16 silylium ion (R3Si(+)) and a hydride (H(-)) reducing agent.

17 using a binuclear copper complex and a mild reducing agent.

18 vely, in the presence of Cys, with AB as the reducing agent.

19 cross-linked mutant was treated with a thiol-reducing agent.

20 ethylene glycol), is validated as the actual reducing agent.

21 presence of glutathione as a stoichiometric reducing agent.

22 of viral particles with membrane-impermeable reducing agent.

23 nitroepoxides with primary amines and then a reducing agent.

24 eductive amination employing hydrogen as the reducing agent.

25 200 muM) of inhibitory activity with another reducing agent.

26 th introduced cysteines and was sensitive to reducing agent.

27 ll molecule mycothiol (MSH) as their primary reducing agent.

28 ls, and this effect was recapitulated with a reducing agent.

29 mpounds utilizing dimethylethylsilane as the reducing agent.

30 a radical pathway with dimsyl potassium as a reducing agent.

31 bismuthinidene catalysts, aided by HBpin as reducing agent.

32 ng the precursor by an electron beam without reducing agent.

33 he utility of alkali metal salts as a charge-reducing agent.

34 phosphine source and diphenyldisiloxane as a reducing agent.

35 n-situ, one-step method without the use of a reducing agent.

36 d as a precatalyst and trimethoxysilane as a reducing agent.

37 aliphatic aldehydes using zinc metal as the reducing agent.

38 l-glycine) that can function as a reversible reducing agent.

39 i, the latter of which acts as a sacrificial reducing agent.

40 tent superoxide anion radical scavengers and reducing agents.

41 using aged tissue in the presence of excess reducing agents.

42 ny potassium tartrate are added and serve as reducing agents.

43 e channels with thiol-oxidizing or disulfide-reducing agents.

44 concentration of guanidine hydrochloride and reducing agents.

45 e complexes might be accessible using strong reducing agents.

46 d inter-disulphide bond by using appropriate reducing agents.

47 -5-MTHF can be controlled by the presence of reducing agents.

48 uman topoisomerase IIalpha in the absence of reducing agents.

49 uced blocking was reversed by disulfide bond-reducing agents.

50 breast cancer cells with increased levels of reducing agents.

51 t a denaturation step, and in the absence of reducing agents.

52 IDO1 activity through the supply of heme and reducing agents.

53 yet it readily disassembles upon exposure to reducing agents.

54 gain can be eliminated by adding appropriate reducing agents.

55 ffect was fully reversible by treatment with reducing agents.

56 amenable to therapeutic intervention by GSL reducing agents.

57 The addition of reducing agents (0.05%, w/w) mitigated during toasting n

58 rried out in the presence and absence of the reducing agent 2-ME indicated that the predicted affinit

59 By introducing a compatible reducing agent (2-ethylimidazole) into a mono-micelle as

60 support the formation of a second, stronger reducing agent: a hydrogen-bonded complex between BH* an

61 Denaturants, reducing agents, acidic buffers, and thermal processing

62 Unlike other reducing agents, addition of SO2 to must/wine upon heati

63 ct advantages over the use of excess soluble reducing agent alone.

64 More importantly, we found that various reducing agents altered inhibitor potency (IC(50)) from

65 synthesis of silver nanoparticles employs a reducing agent and a capping agent.

66 features the use of 2-picoline borane as the reducing agent and a protic solvent for the reaction med

67 solated protein to an iron salt, a disulfide reducing agent and air.

68 Using a moderate reducing agent and an epoxide substrate analogue, we wer

69 Simultaneous activation of both the reducing agent and carbon dioxide is the key to efficien

70 nitro compound) in the presence of the same reducing agent and catalyst.

71 esonance appears only in the presence of the reducing agent and disappears readily upon exposure to a

72 ll molecule mycothiol (MSH) as their primary reducing agent and for the detoxification of xenobiotics

73 py using sodium napthalenide (NaNpth) as the reducing agent and found that Mo-bpy undergoes anionic p

74 -kDa moiety was detected in SDS-PAGE without reducing agent and heat inactivation.

75 es were characterized after treatment with a reducing agent and heavy ion probes to reveal the occurr

76 Acting as a simultaneous reducing agent and In source, In(I)Cl smoothly reacts wi

77 The amine ligand serves as a strong reducing agent and is likely the main participant in the

78 a novel biocomposite, using ascorbic acid as reducing agent and microfibrillated cellulose as a cappi

79 ith ammonia or an amine in the presence of a reducing agent and often a catalyst, is an important ami

80 solvent (ethylene glycol) is considered the reducing agent and poly(N-vinylpyrrolidone) (PVP) the sh

81 n-resistant S. aureus (MRSA) was used as the reducing agent and protective group to generate DD-immob

82 +) electrolyte by utilizing formic acid as a reducing agent and Pt/C as a catalyst.

83 borohydride (MEt3BH, M = Na, K) as both the reducing agent and reaction medium.

84 al reduction of Ag or Au ions using PVA as a reducing agent and stabilizer.

85 osphorus atom depending on the nature of the reducing agent and the presence of additives.

86 alyst both in the presence of a one-electron reducing agent and under electrochemically assisted cond

87 -nitrosocyclohexyl acetate are reversible by reducing agents and distinct from those of another HNO d

88 is indeed oxygen tolerant in the absence of reducing agents and sulfides by means of reaching an O(2

89 reaction occurred in the absence of O(2) and reducing agents and was not inhibited by superoxide dism

90 to dissociation by boiling, denaturants, or reducing agents and was not observed in vitro unless bot

91 lyst, no dependence upon the amount of zinc (reducing agent), and an inverse dependence upon aryl hal

92 The protecting group was matched to the reducing agent, and following optimization, a series of

93 al 10-hydroxylase that requires SAM, a thiol reducing agent, and molecular oxygen for activity.

94 Combinations of ligand, reducing agent, and reaction conditions have been identi

95 yde reductive coupling reactions with silane reducing agents are investigated using density functiona

96 ll as the use of reactive trihydrosilanes as reducing agents are keys to success.

97 The reducing agents are reviewed under two major categories:

98 ing electrochemical exfoliation, a series of reducing agents as additives (e.g., (2,2,6,6-tetramethyl

99 rbic acid and antimony potassium tartrate as reducing agents (as used in the colorimetric method).

100 t CH4 was a highly efficient and a versatile reducing agent, as the total reducing power of CH4 origi

101 h of incubation after addition of biological reducing agent ascorbate at the physiological concentrat

102 fection by treatment with the small-molecule reducing agent ascorbic acid (vitamin C).

103 The addition of a reducing agent (ascorbic acid) plays a key role in this

104 fect on the degradation in the presence of a reducing agent (ascorbic acid), while in the mere presen

105 silver nitrate solution in the presence of a reducing agent, ascorbic acid, using in situ liquid-cell

106 ith nanowire morphology using a nonhazardous reducing agent, ascorbic acid.

107 nd AgNPs were synthesized using quercetin as reducing agent at room temperature.

108 f the complex reactivity of PAHs with strong reducing agents at high temperature.

109 mediated ATRP and supplemental activator and reducing agent ATRP up to high conversion (>90%), in t <

110 anoparticles synthesized using amino acid as reducing agent (average diameter-20 nm), incorporate the

111 For the irradiation of CO(2) using H(2)O as reducing agent, basic solids (K(+)-exchanged Y zeolite o

112 le DIBAL-H appeared to be the most efficient reducing agent because it exhibited high diastereoselect

113 Metallic aluminum (Al) is of interest as a reducing agent because of its low standard reduction pot

114 The reducing agent beta-ME had little effect on zein's abili

115 The reducing agent beta-mercaptoethanol (betaME) reversibly

116 potassium-competitive acid blockers, reflux-reducing agents, bile acid binders, injection of inert s

117 requires slow reduction effected by a weaker reducing agent, borane-tert-butylamine complex.

118 is study reports a new, green, and efficient reducing agent (caffeic acid/CA) for GO reduction.

119 actions, involving molecular hydrogen as the reducing agent, can be promoted by heterogeneous and hom

120 ed during acute hypoxia and both hypoxia and reducing agents caused functional inhibition of Complex

121 of oxalate (C(2)O(4)(2-)) produces a strong reducing agent, CO(2)(*-).

122 es and aminoborohydrides are mild, selective reducing agents complementary to the commonly utilized a

123 er with tris(2-carboxyethyl)phosphine as the reducing agent, conditions under which palmitoylation wa

124 Toasted bread without reducing agents contained typical Maillard reaction comp

125 The addition of a reducing agent converts them to the reduced, free thiol

126 and 1.3(0.5) x 10(20) cm(-3) for the weaker reducing agent, CrCp*2.

127 evels of silencing by addition of a chemical reducing agent, demonstrating a basis for external contr

128 fer additives, including dimethyl sulfoxide, reducing agents, detergents, and bovine serum albumin.

129 In the absence of a reducing agent, dG(N(1)-H)(*) oxidizes 3, decreasing the

130 Reducing agents did not alter the activity, while amino

131 sic levels of reactive oxygen species (ROS); reducing agents dissociate NS into monomers and dimers.

132 Deoxygenation of Hb was initiated using the reducing agent dithiothreitol (DTT) in an assay that all

133 Preincubation with the reducing agent dithiothreitol (DTT, 1 mM) prevented drug

134 ontracted airways were mimicked by the thiol-reducing agent dithiothreitol (DTT, 10 mm) and inhibited

135 tion, current inhibition was reversed by the reducing agent dithiothreitol and unaffected by 1H-[1,2,

136 Furthermore, bath application of the reducing agent dithiothreitol increased the NMDAR compon

137 Addition of the reducing agent dithiothreitol to wild-type cells had a s

138 ld not be reversed by the application of the reducing agent dithiothreitol.

139 mycin A-induced TRPA1 activation, as did the reducing agent dithiothreitol.

140 nd cell-cell fusion only after exposure to a reducing agent, dithiothreitol (DTT).

141 tered redox state as bath application of the reducing agent, dithiothreitol, increased the NMDAR comp

142 s precursor, N-acetylcysteine, or adding the reducing agent, dithiothreitol, lessened the response.

143 Here, we compared the effects of three reducing agents-dithiothreitol (DTT), beta-mercaptoethan

144 Weak reducing agents do not facilitate defect formation by ou

145 of neurons responding to OA-NO2; however, a reducing agent DTT (50 mm) or La(3+) (50 mum) completely

146 he exogenous application of GSH or the thiol-reducing agent DTT can rescue the root phenotype of miao

147 en identified; these states are sensitive to reducing agents due to the formation of nonnative disulf

148 ch act both as a source of catalyst and as a reducing agent during surface-initiated atom transfer ra

149 er amino acid-depleted conditions and that a reducing agent effectively suppresses amino acid-induced

150 rochemical methods use electrons directly as reducing agents, eliminating the need for harmful chemic

151 sing 9-borabicyclo[3.3.1]nonane (9-BBN) as a reducing agent enabled a time-dependent investigation ba

152 cessible and hydrogen is the most attractive reducing agent, especially if large-scale product format

153 graphene oxide were reduced together with a reducing agent, ethylene glycol.

154 ith amines utilizing iron pentacarbonyl as a reducing agent followed by subsequent oxidation leads to

155 meation column chromatography, and used as a reducing agent for the synthesis of silver-betanin core-

156 here for the first time to activate Al as a reducing agent for wet-chemical synthesis of a diverse a

157 alytic metal and are dependent on oxygen and reducing agents for activity.

158 atform to understand the efficiency of these reducing agents for the reduction of graphene oxide.

159 Aminoborohydrides are powerful and selective reducing agents for the reduction of tertiary amides.

160 anowires respectively, indicating the faster reducing agent formed kinetically preferred nanowires.

161 rization via initial reduction by biological reducing agent glutathione (GSH), followed by binding of

162 ally relevant concentrations of the cellular reducing agent glutathione.

163 which is abundant in reactions with a minor reducing agent, glutathione.

164 trong P horizontal lineO bond by BH3, a mild reducing agent, has been achieved through an intramolecu

165 fication of drug leads, and nonphysiological reducing agents have been widely used for HTS.

166 nical trials for symptomatic AD with amyloid-reducing agents have succeeded at target engagement but

167 ies showed that the addition of detergent or reducing agent improved extraction efficiency of peanut

168 gestion protocol using dithiothreitol as the reducing agent in ammonium bicarbonate buffer could resu

169 Therefore, the choice of reducing agent in an HTS is critical because this may le

170 mmon synthetic polymer widely used as a drag reducing agent in aqueous flows.

171 d) icosahedral nanocrystals based on the gas reducing agent in liquid solution method.

172 carbon organic radicals have been used as a reducing agent in metal nanowire synthesis.

173 using inexpensive polymethylhydrosiloxane as reducing agent in methanol.

174 ay have therapeutic potential as an arginine-reducing agent in patients with arginase deficiency.

175 It is also shown to act as a two-electron reducing agent in reactions with unsaturated substrates.

176 s N-acetylcysteine as a stoichiometric thiol reducing agent in the aqueous phase.

177 hase system containing N-acetylcysteine as a reducing agent in the aqueous phase.

178 Elemental silver was used as a reducing agent in the atom transfer radical polymerizati

179 Using tetramethyldisiloxane (TMDS) as a mild reducing agent in the presence of copper complexes, PO b

180 ives NH(3) partly from its desired role as a reducing agent in the SCR and diminishes NO conversion a

181 film, which prevents its effective use as a reducing agent in wet-chemical synthesis.

182 mpared to quantify uric acid and antioxidant reducing agents in 36 milk samples.

183 active and potentially useful stoichiometric reducing agents in nonpolar, nonprotonated solvents.

184 iodide (SmI(2)) is one of the most important reducing agents in organic synthesis.

185 tes, and in the presence of growth media and reducing agents, in addition to preserving their optical

186 and is stimulated by ferrous/ferric ion and reducing agents including L-ascorbate.

187 as reversed upon exposure to the thiol-based reducing agents, including physiologically relevant conc

188 discovered that macromolecular crowding and reducing agents increase overall iSAT protein synthesis;

189 e iSAT yields by enhancing translation while reducing agents increase rRNA transcription and ribosome

190 32Ser mutation or by treatment of cells with reducing agents increases Z AAT secretion.

191 is altered by changing redox balance using a reducing agent-indicating gap junction nexus stability i

192 t temperature and pressure in the absence of reducing agent is exploited which resulted good-to-high

193 ATRP of alkyne-terminated polymers because a reducing agent is present during polymerization, however

194 es an inexpensive iron catalyst and a silane reducing agent is reported.

195 ) spectroscopic studies show that the active reducing agent is the free radicals produced by benzoins

196 talyzed by Ni(COD)(2)/PCy(3) with silanes as reducing agents is reported herein.

197 , ascorbic acid (vitamin C, a potent natural reducing agent) is a common additive to cell culture med

198 with aqueous, buffered sodium formate as the reducing agent, is catalyzed by a cyclometallated iridiu

199 to the general understanding of NaBH(4) as a reducing agent, it has also been found to act as a cappi

200 (water), (ii) SiGe alloy composition, (iii) reducing agent, (iv) metal redox potential, and (v) addi

201 in added amounts of soy lecithin, salt, and reducing agents (l-cysteine and glutathione).

202 f [Rh2(OAc)4] as catalyst and formic acid as reducing agent, leading to the high yield synthesis of c

203 is new approach involves the use of a strong reducing agent, LiAlH(4), to completely reduce both HAT

204 tivity of NP in the presence of oxygen and a reducing agent like DTT.

205 have suggested that ivabradine, a heart-rate-reducing agent, may improve outcomes in patients with st

206 The reducing agent, mercaptopropionylglycine, or the CaMKII

207 o-occlusion was blocked by the methemoglobin reducing agent methylene blue, haptoglobin, or the heme-

208 t releases luciferin in the presence of mild reducing agents, molecular oxygen, and no additional cof

209 The reducing agent N-acetylcysteine eliminated the effects o

210 line Pd nanoparticles synthesized by another reducing agent (N2H4) and commercial Pt-loaded carbon (P

211 n be controlled by varying the amount of the reducing agent NaBH4 in the synthesis, and the prepared

212 peroxide that acted as the measurand and the reducing agent of the Au(III)/citrate system in the flow

213 Trxs act as potential reducing agents of disulfide bonds and contain two vicin

214 vior of mEos3.2 and mMaple3 is modified by a reducing agent, offering the possibility to adjust blink

215 agents such as Trolox, a combined oxidizing-reducing agent often used in single-molecule studies for

216 ulfide bond is demonstrated by the effect of reducing agents on the precursor, mutagenesis, and liqui

217 molecular electron transfer from an external reducing agent or mediated intramolecularly by internal

218 d to the monovalent cation PQ(+) by either a reducing agent or NADPH oxidase on microglia, it becomes

219 its pores without the need for any external reducing agent or photochemical reactions, and the resul

220 own via a colloidal approach with a chemical reducing agent or synthesized with an applied current on

221 pecies scavenger N-acetylcysteine but not by reducing agents or NO pathway inhibitors.

222 olerance to oxygen, and no need to introduce reducing agents or radical initiators.

223 ox-dependent inhibition by either artificial reducing agents or TRXo1 itself.

224 ate (SDS, surfactant), beta-mercaptoethanol (reducing agent) or ethylenediaminetetraacetic acid (EDTA

225 r redox-flow battery applications, selective reducing agents, or organic electronics.

226 al limitations of NAC and test a novel mucin-reducing agent, P3001, in preclinical settings.

227 e of metal precursor and the strength of the reducing agent play a key role in achieving the desired

228 emoval of copper catalyst; (2) adding excess reducing agents post-ATRP which prevent the oxidation of

229 LsAA9A activity is less sensitive to the reducing agent potential when cleaving xylan, suggesting

230 mately 650 mV can be associated with further reducing agents present in milk.

231 roups of cellulose nanofibers, acting as the reducing agent producing a bionanocomposite "embedded si

232 nthesis through the addition of crowding and reducing agents, provides a thorough understanding of th

233 ors has not been done with the physiological reducing agent reduced glutathione (GSH).

234 taining DNA 6-TG induces extensive heat- and reducing agent-resistant covalent DNA-protein crosslinks

235 n is accelerated by H(2)O(2) and hindered by reducing agents, resulting in faster and slower aggregat

236 cellular uptake and were less susceptible to reducing agents, resulting in greater transfection effic

237 o inhibited IKK activation directly, and the reducing agent reversed this inhibition.

238 oncomitant exposure of the fused proteins to reducing agents severely limits the scope of protein tra

239 ion without the need for ionic surfactant or reducing agents, simplifying device design and operation

240 Rather, we confirm that it is the reducing agent sodium dithionite that facilitates releas

241 ed for 10 s into two separate solutions of a reducing agent (sodium hypophosphite (NaH2PO2)) and Pd i

242 esis of metal nanoparticles, often acting as reducing agents, solvents, and stabilizers.

243 rons, plates, or cubes) together with a weak reducing agent such as citric acid (CA).

244 HO in the presence of oxygen and biological reducing agents such as ascorbate.

245 growth media, and in the presence of natural reducing agents such as glutathione.

246 yet most synthesis recipes require hazardous reducing agents such as hydrazine or sodium borohydride.

247 ein splicing, and splicing can be induced by reducing agents such as tris(2-carboxyethyl)phosphine (T

248 Other reducing agents such as tris(2-carboxyethyl)phosphine an

249 adation can be enhanced by the presence of a reducing agent, such as ascorbic acid.

250 A reducing agent, such as dithionite, which can quench the

251 . coli SufS that is partially protected from reducing agents, such as dithiothreitol and glutathione,

252 Of note, exposure to gastric acid-reducing agents, such as H2 blockers and proton pump inh

253 complementary to the commonly utilized amide reducing agents, such as lithium aluminum hydride (LiAlH

254 ing compounds (~560 compounds) with the four reducing agents surprisingly produced many nonoverlappin

255 y more resistant to chemical denaturants and reducing agents than nepenthesin I, and it possesses a s

256 ganic radical great potential as a versatile reducing agent that can be generalized in other metallic

257 when the system is continuously fueled by a reducing agent that keeps it far from equilibrium, and o

258 owever, the effect of CORM-2 was reversed by reducing agents that act extracellularly.

259 e inhibitors such as statins are cholesterol-reducing agents that may provide a new therapeutic optio

260 At the same time, water-soluble reducing agents that regenerate alphatoc can access the

261 For strong reducing agents the initial outer-sphere electron transf

262 By employing a trialkylamine as a reducing agent, the active Pd(0) species is generated in

263 In the absence of an external reducing agent, the in-situ-generated oxidative addition

264 recursor and potassium graphite (KC(8)) as a reducing agent, the naphthalene and anthracene complexes

265 Requiring no reducing agents, the protocol provides an easy, alternat

266 At pH 7, in the absence of reducing agents, these Ap-containing duplexes also produ

267 5 to DNA, and this binding was reversed by a reducing agent, thus suggesting a role for the cysteine

268 uses potassium hydride as a redox-controlled reducing agent to access the PAH dianions, and so enable

269 ccess relies on the introduction of a strong reducing agent to compete with and thereby block the gal

270 (IC(50)) from approximately 10 muM with one reducing agent to complete loss (IC(50)>200 muM) of inhi

271 nanopores of Zn-MOF using acetic acid as the reducing agent to fabricate Au-NP@Zn-MOF nanocomposites.

272 ontaining active site and use dioxygen and a reducing agent to oxidatively cleave glycosidic linkages

273 from Tagetespatula was used as a capping and reducing agent to synthesize in one pot gold nanoparticl

274 olloidal growth solution by tailoring a weak reducing agent to the measured potential profile of the

275 onds are reduced chemically by addition of a reducing agent to the quench solution (e.g., tris(2-carb

276 acceptor, we used iron(II) and glucose as co-reducing agents to reduce GO under mild reaction conditi

277 f applying Mannose-6-Phosphate (M6P), a scar reducing agent, to a site of sciatic nerve repair.

278 k reaction, now performed in the presence of reducing agent, to generate cross-linked DNA or a pyrene

279 (2)O(2) production enhanced by addition of a reducing agent, to simulate availability of reducible su

280 luoride anion does not act as a one-electron reducing agent toward the NDI investigated in this work.

281 high concentration (>200 mM) of the chemical reducing agent Tris(2-carboxyethyl)phosphine (TCEP) as i

282 The use of a stronger reducing agent [tris(2-carboxyethyl)phosphine hydrochlor

283 Using H(2) gas as reducing agent, up to 40% conversion was achieved with a

284 ce in the HTS results based on the choice of reducing agent used and potency comparisons of selected

285 as hydride source as well as glucose as the reducing agent used in stoichiometric amounts for in sit

286 mperature, solvent, substituent, and type of reducing agent using a synergistic experimental-computat

287 nanoparticles mediated by stainless steel as reducing agent was monitored via infrared attenuated tot

288 d that a sufficient concentration of the TEA reducing agent was present in solution.

289 sphate buffer containing both surfactant and reducing agent was used as the extraction buffer.

290 lipophilic naphthyridinol with water-soluble reducing agents was also studied in liposomes using H(2)

291 Attempts to restore fusion with a reducing agent were unsuccessful, suggesting that the in

292 phosphatidylcholine lipids can act as charge-reducing agents when dissociated from native membrane pr

293 out in the presence of significant levels of reducing agents (which should reduce etoposide quinone t

294 is facilitated by visible light and a silane reducing agent, which trigger a distinct radical initiat

295 Oxidizing and reducing agents, which are currently involved in cell me

296 This modification is reversible by reducing agents, which restore APE1 incision function.

297 ewis basic fragment allows activation of the reducing agent while moderate Lewis acidity/basicity at

298 duction, consisting of more than 50 types of reducing agent, will be reviewed from a synthetic chemis

299 eaction of the electrogenerated Pt phases as reducing agent with phenyl diazonium salts was performed

300 ylmetal reagent is needed, only nickel and a reducing agent (Zn).